{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:44:38Z","timestamp":1782953078813,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-27386-1","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:43:41Z","timestamp":1778283821000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An updated pharmacovigilance evidence from U.S. tobacco problem reports following the FDA safety communication on e-cigarettes and seizures"],"prefix":"10.1186","volume":"26","author":[{"given":"Danila","family":"Azzolina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Bartolotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martino Belvederi","family":"Murri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Gregori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"27386_CR1","unstructured":"World Health Organization. WHO report on the global tobacco epidemic 2021: addressing new and emerging products . World Health Organization; luglio 2021. Report No.: Eighth Report. Disponibile su: https:\/\/www.who.int\/publications\/i\/item\/9789240032095"},{"issue":"45","key":"27386_CR2","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.15585\/mmwr.mm7145a1","volume":"71","author":"E Park-Lee","year":"2022","unstructured":"Park-Lee E, Ren C, Cooper M, Cornelius M, Jamal A, Cullen KA. Tobacco Product Use Among Middle and High School Students \u2014 United States, 2022. Morb Mortal Wkly Rep MMWR novembre. 2022;71(45):1429\u201335. https:\/\/doi.org\/10.15585\/mmwr.mm7145a1.","journal-title":"Morb Mortal Wkly Rep MMWR novembre"},{"issue":"2","key":"27386_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/tobaccocontrol-2012-050859","volume":"23","author":"ML Goniewicz","year":"2014","unstructured":"Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control marzo. 2014;23(2):133\u20139. https:\/\/doi.org\/10.1136\/tobaccocontrol-2012-050859. PubMed PMID: 23467656; PubMed Central PMCID: PMC4154473.","journal-title":"Tob Control marzo"},{"issue":"17","key":"27386_CR4","doi-asserted-by":"publisher","first-page":"9644","DOI":"10.1021\/acs.est.6b01741","volume":"50","author":"M Sleiman","year":"2016","unstructured":"Sleiman M, Logue JM, Montesinos VN, Russell ML, Litter MI, Gundel LA, et al. Emissions from Electronic Cigarettes: Key Parameters Affecting the Release of Harmful Chemicals. Environ Sci Technol 6 settembre. 2016;50(17):9644\u201351. https:\/\/doi.org\/10.1021\/acs.est.6b01741.","journal-title":"Environ Sci Technol 6 settembre"},{"key":"27386_CR5","doi-asserted-by":"publisher","unstructured":"Gotts JE, Jordt SE, McConnell R, Tarran R. What are the respiratory effects of e-cigarettes? BMJ. 30 settembre 2019;l5275. https:\/\/doi.org\/10.1136\/bmj.l5275","DOI":"10.1136\/bmj.l5275"},{"issue":"8","key":"27386_CR6","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1164\/rccm.201604-0804OC","volume":"195","author":"R McConnell","year":"2017","unstructured":"McConnell R, Barrington-Trimis JL, Wang K, Urman R, Hong H, Unger J, et al. Electronic Cigarette Use and Respiratory Symptoms in Adolescents. Am J Respir Crit Care Med 15 aprile. 2017;195(8):1043\u20139. https:\/\/doi.org\/10.1164\/rccm.201604-0804OC. PubMed PMID: 27806211; PubMed Central PMCID: PMC5422647.","journal-title":"Am J Respir Crit Care Med 15 aprile"},{"issue":"3","key":"27386_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1001\/jamacardio.2016.5303","volume":"2","author":"RS Moheimani","year":"2017","unstructured":"Moheimani RS, Bhetraratana M, Yin F, Peters KM, Gornbein J, Araujo JA, et al. Increased Cardiac Sympathetic Activity and Oxidative Stress in Habitual Electronic Cigarette Users: Implications for Cardiovascular Risk. JAMA Cardiol 1 marzo. 2017;2(3):278. https:\/\/doi.org\/10.1001\/jamacardio.2016.5303.","journal-title":"JAMA Cardiol 1 marzo"},{"issue":"8","key":"27386_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrcardio","volume":"14","author":"NL Benowitz","year":"2017","unstructured":"Benowitz NL, Fraiman JB. Cardiovascular effects of electronic cigarettes. Nat Rev Cardiol agosto. 2017;14(8):447\u201356. https:\/\/doi.org\/10.1038\/nrcardio. 2017.36 PubMed PMID: 28332500; PubMed Central PMCID: PMC5519136.","journal-title":"Nat Rev Cardiol agosto"},{"key":"27386_CR9","unstructured":"Food US, Administration D. FDA encourages continued submission of reports related to seizures following e-cigarette use as part of agency\u2019s ongoing scientific investigation of potential safety issue . 2019. Disponibile su: https:\/\/www.fda.gov\/news-events\/fda-brief\/fda-brief-fda-encourages-continued-submission-reports-related-seizures-following-e-cigarette-use"},{"key":"27386_CR10","unstructured":"U.S. Food and Drug Administration. E-cigarette: Safety Communication \u2013 Related to Seizures Reported Following E-cigarette Use, Particularly in Youth and Young Adults . 2019. Disponibile su: https:\/\/www.fda.gov\/safety\/medical-product-safety-information\/e-cigarette-safety-communication-related-seizures-reported-following-e-cigarette-use-particularly-in-youth-and-young-adults"},{"key":"27386_CR11","unstructured":"Food US, Administration D. E-Cigarette: Safety Communication - Related to Seizures Reported Following E-Cigarette Use, Particularly in Youth and Young Adults . 2019. Disponibile su: https:\/\/www.fda.gov\/safety\/medical-product-safety-information\/e-cigarette-safety-communication-related-seizures-reported-following-e-cigarette-use-particularly"},{"issue":"10","key":"27386_CR12","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1056\/NEJMoa1911614","volume":"382","author":"JE Layden","year":"2020","unstructured":"Layden JE, Ghinai I, Pray I, Kimball A, Layer M, Tenforde MW, et al. Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin \u2014 Final Report. N Engl J Med 5 marzo. 2020;382(10):903\u201316. https:\/\/doi.org\/10.1056\/NEJMoa1911614.","journal-title":"N Engl J Med 5 marzo"},{"issue":"3","key":"27386_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.15585\/mmwr.mm6903e2","volume":"69","author":"VP Krishnasamy","year":"2020","unstructured":"Krishnasamy VP, Hallowell BD, Ko JY, Board A, Hartnett KP, Salvatore PP, et al. Update: Characteristics of a Nationwide Outbreak of E-cigarette, or Vaping, Product Use\u2013Associated Lung Injury \u2014 United States, August 2019\u2013January 2020. Morb Mortal Wkly Rep gennaio. 2020;69(3):90\u20134. https:\/\/doi.org\/10.15585\/mmwr.mm6903e2.","journal-title":"Morb Mortal Wkly Rep gennaio"},{"issue":"6","key":"27386_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/pds.1742","volume":"18","author":"A Bate","year":"2009","unstructured":"Bate A, Evans SJW. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf giugno. 2009;18(6):427\u201336. https:\/\/doi.org\/10.1002\/pds.1742.","journal-title":"Pharmacoepidemiol Drug Saf giugno"},{"key":"27386_CR15","doi-asserted-by":"publisher","first-page":"1323057","DOI":"10.3389\/fdsfr.2023.1323057","volume":"3","author":"PM Cutroneo","year":"2024","unstructured":"Cutroneo PM, Sartori D, Tuccori M, Crisafulli S, Battini V, Carnovale C, et al. Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems. Front Drug Saf Regul 26 gennaio. 2024;3:1323057. https:\/\/doi.org\/10.3389\/fdsfr.2023.1323057.","journal-title":"Front Drug Saf Regul 26 gennaio"},{"issue":"1","key":"27386_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/pds.668","volume":"11","author":"EP Van Puijenbroek","year":"2002","unstructured":"Van Puijenbroek EP, Bate A, Leufkens HGM, Lindquist M, Orre R, Egberts ACG. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf gennaio. 2002;11(1):3\u201310. https:\/\/doi.org\/10.1002\/pds.668.","journal-title":"Pharmacoepidemiol Drug Saf gennaio"},{"issue":"8","key":"27386_CR17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pds.1001","volume":"13","author":"KJ Rothman","year":"2004","unstructured":"Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf agosto. 2004;13(8):519\u201323. https:\/\/doi.org\/10.1002\/pds.1001.","journal-title":"Pharmacoepidemiol Drug Saf agosto"},{"issue":"7","key":"27386_CR18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2165\/00002018-200730070-00011","volume":"30","author":"A Bate","year":"2007","unstructured":"Bate A. Bayesian Confidence Propagation Neural Network. Drug Saf. 2007;30(7):623\u20135. https:\/\/doi.org\/10.2165\/00002018-200730070-00011.","journal-title":"Drug Saf"},{"issue":"1","key":"27386_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0962280211403604","volume":"22","author":"GN Nor\u00e9n","year":"2013","unstructured":"Nor\u00e9n GN, Hopstadius J, Bate A. Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery. Stat Methods Med Res febbraio. 2013;22(1):57\u201369. https:\/\/doi.org\/10.1177\/0962280211403604.","journal-title":"Stat Methods Med Res febbraio"},{"issue":"2","key":"27386_CR20","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/ntr\/nts145","volume":"15","author":"Chen","year":"2013","unstructured":"Chen, FDA Summary of Adverse Events on Electronic Cigarettes. Nicotine Tob Res 1 febbraio. 2013;15(2):615\u20136. https:\/\/doi.org\/10.1093\/ntr\/nts145.","journal-title":"Nicotine Tob Res 1 febbraio"},{"issue":"46","key":"27386_CR21","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.15585\/mmwr.mm6846e1","volume":"68","author":"K Chatham-Stephens","year":"2019","unstructured":"Chatham-Stephens K, Roguski K, Jang Y, Wiltz JL. others. Characteristics of Hospitalized and Nonhospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use\u2013Associated Lung Injury \u2014 United States, November 2019. Morb Mortal Wkly Rep 22 novembre. 2019;68(46):1076\u201380.","journal-title":"Morb Mortal Wkly Rep 22 novembre"},{"issue":"8","key":"27386_CR22","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1056\/NEJMoa1916433","volume":"382","author":"BC Blount","year":"2020","unstructured":"Blount BC, Karwowski MP, Shields PG, Morel-Espinosa M, Valentin-Blasini L, Gardner M, et al. Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI. N Engl J Med 20 febbraio. 2020;382(8):697\u2013705. https:\/\/doi.org\/10.1056\/NEJMoa1916433.","journal-title":"N Engl J Med 20 febbraio"},{"key":"27386_CR23","doi-asserted-by":"publisher","first-page":"1179173X2412796","DOI":"10.1177\/1179173X241279674","volume":"17","author":"SA Barrientos","year":"2024","unstructured":"Barrientos SA, Dabroy D, Ebrahimi Kalan M, Laestadius LI, Ben Taleb Z. Tobacco and Nicotine Products Adverse Health Events: Findings From the FDA Safety Reporting Portal. Tob Use Insights febbraio. 2024;17:1179173X241279674. https:\/\/doi.org\/10.1177\/1179173X241279674.","journal-title":"Tob Use Insights febbraio"},{"issue":"6","key":"27386_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"SJW Evans","year":"2001","unstructured":"Evans SJW, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf ottobre. 2001;10(6):483\u20136. https:\/\/doi.org\/10.1002\/pds.677.","journal-title":"Pharmacoepidemiol Drug Saf ottobre"},{"key":"27386_CR25","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing . Vienna, Austria: R Foundation for Statistical Computing. 2015. Disponibile su: https:\/\/www.R-project.org\/"},{"key":"27386_CR26","unstructured":"Stanford T, pharmsignal. Signal detection in pharmacological data (pharmacovigilance) . 2025. Disponibile su: https:\/\/github.com\/tystan\/pharmsignal"},{"issue":"11","key":"27386_CR27","doi-asserted-by":"publisher","first-page":"e1915494","DOI":"10.1001\/jamanetworkopen.2019.15494","volume":"2","author":"JM Yingst","year":"2019","unstructured":"Yingst JM, Hrabovsky S, Hobkirk A, Trushin N, Richie JP, Foulds J. Nicotine Absorption Profile Among Regular Users of a Pod-Based Electronic Nicotine Delivery System. JAMA Netw Open 15 novembre. 2019;2(11):e1915494. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.15494.","journal-title":"JAMA Netw Open 15 novembre"},{"issue":"8","key":"27386_CR28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrcardio.2017.36","volume":"14","author":"NL Benowitz","year":"2017","unstructured":"Benowitz NL, Fraiman JB. Cardiovascular effects of electronic cigarettes. Nat Rev Cardiol agosto. 2017;14(8):447\u201356. https:\/\/doi.org\/10.1038\/nrcardio.2017.36.","journal-title":"Nat Rev Cardiol agosto"},{"issue":"6","key":"27386_CR29","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1136\/tobaccocontrol-2018-054616","volume":"28","author":"S Talih","year":"2019","unstructured":"Talih S, Salman R, El-Hage R, Karam E, Karaoghlanian N, El-Hellani A, et al. Characteristics and toxicant emissions of JUUL electronic cigarettes. Tob Control novembre. 2019;28(6):678\u201380. https:\/\/doi.org\/10.1136\/tobaccocontrol-2018-054616.","journal-title":"Tob Control novembre"},{"issue":"4","key":"27386_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/ntr\/ntv080","volume":"18","author":"S Talih","year":"2016","unstructured":"Talih S, Balhas Z, Salman R, Karaoghlanian N, Shihadeh A. Direct Dripping: A High-Temperature, High-Formaldehyde Emission Electronic Cigarette Use Method. Nicotine Tob Res 11 aprile. 2016;18(4):453\u20139. https:\/\/doi.org\/10.1093\/ntr\/ntv080.","journal-title":"Nicotine Tob Res 11 aprile"},{"key":"27386_CR31","doi-asserted-by":"publisher","unstructured":"Dedefo MG, Kassie GM, Gebreyohannes EA, Lim R, Roughead E, Kalisch Ellett L. Completeness of spontaneously reported adverse drug reactions in 4 databases. Br J Clin Pharmacol. 28 luglio. 2025;bcp.70182. https:\/\/doi.org\/10.1002\/bcp.70182","DOI":"10.1002\/bcp.70182"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-27386-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27386-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27386-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:50:35Z","timestamp":1782949835000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-27386-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["27386"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-27386-1","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study analyzed de-identified data from the FDA Tobacco Problem Reports database, which is publicly available. No patient contact occurred, and no identifiable personal information was accessed. According to applicable regulations, ethical approval and informed consent were not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2013"}}